The respiratory segment, often influenced by seasonal factors, registered a 1.1% increase in value but faced a 4.6% decline ...

The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...

Augmentin, a combination of amoxicillin and clavulanate potassium, maintained its top-selling brand status in the Indian pharmaceutical market, selling around Rs 75-80 crore per month. The strong ...

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better access to quality care, the Pradhan Mantri Jan Arogya Yojana, the National ...

Among them, the cardiac, gastrointestinal, and antidiabetic therapies saw high value growth of 9.5 per cent, 9.6 per cent, and 6 per cent, respectively ...

Four of the top 5 selling products of GSK are antibiotics (Augmentin, Duricef, Ceporex and Velosef). Two of them come from BMS. By having four well established - and relatively old - antibiotic ...

Here are the critical medicines in short supply in the EU, according to the latest available information from the EMA and ...

The Indian QR coding programme meant to protect domestic drug supplies has failed, and is now a gift to the counterfeiters.

GlaxoSmithKline Pharmaceuticals Limited is ... patients. It launched Augmentin ES deploying technology in reaching out to key specialists in ear, nose and throat (ENT) and Paediatrics practice.

Interestingly, the country’s top five brands – Corex (Pfizer), Voveran (Novartis), Human Mixtard (Abbott), Phensedyl (Abbott), Augmentin (GSK) are all MNC brands. "And a foray into branded ...